Barclays Maintains an 'Equalweight' on Molina Healthcare (MOH); Investor Day Focus on Duals Markets and Other Opportunities

Barclays maintains an 'Equalweight' on Molina Healthcare (NYSE: MOH) price target dropped from $30 to $23.

Barclays analyst says, "CEO Mario Molina offered his thoughts on commentary coming from various hospital companies regarding Medicaid utilization. Specifically, he noted that utilization across Molina's health plans continues to be lower than historical averages, and that they are not seeing evidence of trend acceleration."

"Terry Bayer, COO, presented an operations update focusing primarily on health plan business in several key states. Next, CFO John Molina presented an update on the company's 2011 and 2012 outlook, which remains unchanged. Finally, CEO Molina walked investors through longer-term opportunities related to the dual eligible market."

For more ratings news on Molina Healthcare click here and for the rating history of Molina Healthcare click here.

Shares of Molina Healthcare closed at $16.82 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barclays Downgrades Renault SA (RNO:FP) (RNSDF) to Equalweight
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
• Viking Holdings (VIK) PT Raised to $82 at Mizuho